                         SEQUENCE LISTING

<110>  REGULUS THERAPEUTICS INC.
 
<120>  COMPOUNDS AND METHODS FOR ENHANCED CELLULAR UPTAKE

<130>  REGUL-33327/WO-1/ORD

<150>  61/818,441
<151>  2013-05-01

<150>  61/818,447
<151>  2013-05-01

<150>  61/822,115
<151>  2013-05-10

<150>  61/895,708
<151>  2013-10-25

<160>  8     

<170>  PatentIn version 3.5

<210>  1
<211>  8
<212>  RNA
<213>  Artificial sequence

<220>
<223>  Synthetic

<400>  1
cacactcc                                                                 8


<210>  2
<211>  19
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic

<400>  2
acaccattgt cacactcca                                                    19


<210>  3
<211>  18
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic

<400>  3
acaccatgtc acactcca                                                     18


<210>  4
<211>  15
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic

<400>  4
ccattgtcac actcc                                                        15


<210>  5
<211>  17
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic

<400>  5
acaccattgc acactcc                                                      17


<210>  6
<211>  13
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic

<400>  6
ttgtcacact cca                                                          13


<210>  7
<211>  21
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic

<400>  7
ctcgctagcc tctggatttg a                                                 21


<210>  8
<211>  19
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic

<400>  8
acatcagtct gataagcta                                                    19


